Literature DB >> 18030594

Psychometric evaluation of the Schizophrenia Quality of Life Scale (SQLS) in English- and Chinese-speaking Asians in Singapore.

Nan Luo1, Boon-Kheng Seng, Feng Xie, Shu-Chuen Li, Julian Thumboo.   

Abstract

OBJECTIVE: To assess the psychometric properties of the Schizophrenia Quality of Life Scale (SQLS) in Asians with schizophrenia in Singapore.
METHODS: A consecutive sample of outpatients with schizophrenia completed the English or Chinese version of the SQLS and the Short-Form 36 Health Survey (SF-36) twice during two different clinic visits. The patients were also assessed for presence or absence of 22 psychiatric symptoms.
RESULTS: About 202 patients (English-speaking: 140) participated in the study. Correlations between SQLS scales and other measures assessing similar constructs ranged from 0.46 to 0.69 (P < 0.001 for all). For SQLS psychosocial and symptoms/side effects scales, item-to-scale correlations were >0.4, Cronbach's alpha and intra-class correlation coefficient values were close to or exceed 0.7, and Cohen's effect size, standardized response mean, and Guyatt's responsiveness index values approximated or exceeded 0.2 for both SQLS language versions; however, for the energy/motivation scale, item-to-scale correlations (range: 0.08-0.51), reliability (range: 0.46-0.66) and responsiveness (range: 0.04-0.08) statistics were not satisfactory for both SQLS versions.
CONCLUSIONS: The SQLS psychosocial and symptoms/side effects scales are valid, reliable and responsive in Singaporean patients with schizophrenia; the appropriateness of energy/motivation scale requires further investigation.

Entities:  

Mesh:

Year:  2007        PMID: 18030594     DOI: 10.1007/s11136-007-9278-1

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  21 in total

1.  A community-based study of scaling assumptions and construct validity of the English (UK) and Chinese (HK) SF-36 in Singapore.

Authors:  J Thumboo; K Y Fong; D Machin; S P Chan; K H Leon; P H Feng; S T Thio; M L Boe
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

2.  Commentary--goodbye M(C)ID! Hello MID, where do you come from?

Authors:  Holger J Schünemann; Gordon H Guyatt
Journal:  Health Serv Res       Date:  2005-04       Impact factor: 3.402

3.  Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients.

Authors:  H Y Meltzer; S Burnett; B Bastani; L F Ramirez
Journal:  Hosp Community Psychiatry       Date:  1990-08

4.  Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation.

Authors:  R A Deyo; P Diehr; D L Patrick
Journal:  Control Clin Trials       Date:  1991-08

5.  Measuring change over time: assessing the usefulness of evaluative instruments.

Authors:  G Guyatt; S Walter; G Norman
Journal:  J Chronic Dis       Date:  1987

Review 6.  Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.

Authors:  F Guillemin; C Bombardier; D Beaton
Journal:  J Clin Epidemiol       Date:  1993-12       Impact factor: 6.437

Review 7.  Schizophrenia and quality of life.

Authors:  H Katschnig
Journal:  Acta Psychiatr Scand Suppl       Date:  2000

8.  Self-report quality of life measure for people with schizophrenia: the SQLS.

Authors:  G Wilkinson; B Hesdon; D Wild; R Cookson; C Farina; V Sharma; R Fitzpatrick; C Jenkinson
Journal:  Br J Psychiatry       Date:  2000-07       Impact factor: 9.319

9.  Comparison of quality of life with standard of living in schizophrenic out-patients.

Authors:  K Skantze; U Malm; S J Dencker; P R May; P Corrigan
Journal:  Br J Psychiatry       Date:  1992-12       Impact factor: 9.319

10.  What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D.

Authors:  Stephen J Walters; John E Brazier
Journal:  Health Qual Life Outcomes       Date:  2003-04-11       Impact factor: 3.186

View more
  7 in total

Review 1.  Measuring quality of life in patients with schizophrenia: an update.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  Pharmacoeconomics       Date:  2012-03       Impact factor: 4.981

2.  Validation of the care transition measure in multi-ethnic South-East Asia in Singapore.

Authors:  Anu Birla Bakshi; Shiou-Liang Wee; Charlene Tay; Loong-Mun Wong; Ian Yi-Onn Leong; Reshma A Merchant; Nan Luo
Journal:  BMC Health Serv Res       Date:  2012-08-16       Impact factor: 2.655

3.  The Construct of the Schizophrenia Quality of Life Scale Revision 4 for the Population of Taiwan.

Authors:  Chia-Ting Su; Ai-Lun Yang; Chung-Ying Lin
Journal:  Occup Ther Int       Date:  2017-01-31       Impact factor: 1.448

4.  Clarifying pathways to poor psychological health: The mediating role of psychosocial factors in the relationship between general psychopathology and quality of life impairment in patients diagnosed with schizophrenia.

Authors:  Jianlin Liu; Edimansyah Abdin; Swapna Verma; Kang Sim; Siow Ann Chong; Mythily Subramaniam
Journal:  J Clin Psychol       Date:  2019-01-23

5.  Validity, reliability and factor analysis of Persian version of schizophrenia quality of life scale.

Authors:  Nasrin Masaeli; Victoria Omranifard; Mohammad Reza Maracy; Gholam Reza Kheirabadi; Anahita Khedri
Journal:  J Educ Health Promot       Date:  2016-06-23

6.  Correlation Analysis of the Quality of Family Functioning and Subjective Quality of Life in Rehabilitation Patients Living with Schizophrenia in the Community.

Authors:  Ling Wang; Xi-Wang Fan; Xu-Dong Zhao; Bing-Gen Zhu; Hong-Yun Qin
Journal:  Int J Environ Res Public Health       Date:  2020-04-05       Impact factor: 3.390

7.  Patient-reported outcomes in heart failure with preserved vs. reduced ejection fraction: focus on physical independence.

Authors:  Weiting Huang; Tiew-Hwa Katherine Teng; Wan Ting Tay; Arthur Mark Richards; Umesh Kadam; Claire A Lawson; Wataru Shimizu; Seet Yoong Loh; Inder Anand; Carolyn Su Ping Lam
Journal:  ESC Heart Fail       Date:  2020-08-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.